Truist Securities’ Post

Join us on June 26 at 12 PM ET for a deep dive into the future of health care #PriceTransparency. Industry leaders will discuss emerging trends and what comes next. Register for our upcoming webinar.

In our latest health care outlook, we examine: ⇛ The benefits & risks of added reliance on technology ⇛ The current state of deal making in the industry ⇛ How to address the patient journey while navigating financial challenges Read the latest industry outlook from RSM senior analysts @MichaelHaas, @DannySchmidt and @MattWolf: https://rsm.buzz/3XHJXLS

Health systems cannot meet the huge challenges facing them on their own. They need to create partnerships (for value) with life science companies. This requires greater trust to succeed. Being open about the shared value each partner is seeking at the outset is vital and of course being clear about how the patient achieves better value too. #winwinwin #valuebasedhealthcare #valuebasedprocurement

Value based care improves clinical outcomes

As healthcare leaders continue to face an unprecedented list of challenges, harnessing the power of AI-driven analytics has become business-critical. Health Catalyst is proud to be recognized as a leader in helping organizations reduce costs and drive measurable improvement in their patient outcomes.

I don't often post and comment on youtube videos on LinkedIn, but this one from the BCG team featuring two well known figures in the digital health space caught my eye. It is certainly worth listening to, particularly for US centric companies. Looking at the interview from an international lens a number of the comments are interesting: - Clinical validation: firm and clear nod to the fact that digital therapeutics are clinically proven to work and the issue with digital therapeutics market access is not clinical data but rather reimbursement - Digital health product design determines payor mix and payor mix determines commercial strategy - Partnering strategy is driven by need and expectation, and multiple partners may be needed to address different parts of the commercial model; i.e: Payors unlock coverage but not volume, providers can drive volume but not coverage I think Edward really hit the nail on the head on what is the challenge in digital therapeutics, which is we are taking a field of medicine that has never existed before and then trying to create a new area of medicine in 10 years. Its is incredible difficult to do this is a compressed time scale, and kudos to the pioneers in this field like the Pear Therapeutics team that have started charting a course through these choppy waters. #digitalhealth #digitalhealthcare #digitaltherapeutics #dtx

Exciting to see that Takeda's CEO, Christophe Weber, is bringing Value-Based Healthcare (#VBHC) to the World Economic Forum in Davos! His main messages, that fully resonate with me: ⚠️ Value-based healthcare, emphasizing patient outcomes, is a solution to current over-burdened health systems. ⚠️ Data governance establishing standardized collecting, reporting and analyzing would put patients at the centre of decision-making. ⚠️ Trust is vital for ensuring the responsible use of data. 💬 "Importantly, trust is earned only through actions and behaviours. It takes time to build, effort to keep and can be lost quickly. When it comes to data governance, trust means keeping the patient voice and experiences in the centre of reporting, analyzing and decision-making by providing the infrastructure and framework for the responsible use of data." #HealthcareTransformation #PatientOutcomes #PatientRelevantOutcomes #PatientReportedOutcomes

As healthcare leaders continue to face an unprecedented list of challenges, harnessing the power of AI-driven analytics has become business-critical. Health Catalyst is proud to be recognized as a leader in helping organizations reduce costs and drive measurable improvement in their patient outcomes.

Do digital therapeutics (eg. using an app to help manage diabetes) work? According to this interesting conversation - the answer is a resounding YES. If so, why is it not widely adopted? Because it isn't paid for. Agree that CMS and private payors will have to lead the way for pushing this through and it is only a matter of time for that. And according one of the experts on the video - Edward Cox, Head of Digital Health at Pfizer - we are 70-80% there. After all, "medicines that are paid for are medicines that work". Found Corey McCann of Pear Therapeutics's parting word picture particularly compelling - In a world where kids literally grow up around devices today, it only makes sense that these will be a natural solution to solving some of healthcare's biggest challenges in managing chronic disease. Pin Chin Kwok Yoann Sapanel David Pettigrew Moritz Kaffsack #digitaltherapeutics #thefutureofhealth

A quick recap of the big healthcare trends from Q4 2023 written by our FTI Consulting experts! Quarter healthcare trends, risks, opportunities, and regulatory updates directly to your inbox. Read or sign up if you haven’t already: https://lnkd.in/eqCkH9Dw